[1. Jiang YG, Peng Y, Koussougbo KS. Necroptosis: a novel therapeutic target for glioblastoma. Med Hypotheses 2011; 76: 350-2.10.1016/j.mehy.2010.10.037]Search in Google Scholar
[2. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Cell Mol Biol 2008; 9: 231-41.10.1038/nrm2312]Search in Google Scholar
[3. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2009; 16: 3-11.10.1038/cdd.2008.150]Search in Google Scholar
[4. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43.10.1038/sj.cdd.4402060]Search in Google Scholar
[5. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 2: 112-9.10.1038/nchembio711]Search in Google Scholar
[6. Holle, N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 6: 489-95.10.1038/82732]Search in Google Scholar
[7. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation driven assembly of the RIP1 RIP3 complex regulates programmed necrosis and virus induced inflammation. Cell 2009; 137: 1112-23.10.1016/j.cell.2009.05.037]Search in Google Scholar
[8. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332-6.10.1126/science.1172308]Search in Google Scholar
[9. Rollins S, Perkins E, Mandybur G, Zhang JH. Oxyhemoglobin produces necrosis, not apoptosis in astrocytes. Brain Res 2002; 945: 41-9.10.1016/S0006-8993(02)02562-3]Search in Google Scholar
[10. Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol 2004; 72: 111-27.]Search in Google Scholar
[11. Laird MD, Wakade C, Alleyne CH, Dhandapani KM. Hemin induced necroptosis involves glutation depetion in mouse astrocytes. Free Radic Biol Med 2008; 45: 1103-14.10.1016/j.freeradbiomed.2008.07.00318706498]Search in Google Scholar
[12. Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 2004; 1: 181-93.10.1111/j.1471-4159.2004.02144.x]Search in Google Scholar
[13. Šimenc J, Lipnik-Štangelj M. Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes. Drug Chem Toxicol 2012; 35: 399-405.10.3109/01480545.2011.633087]Search in Google Scholar
[14. Eruslanov E. Kusmartsev S. Identification of ROS using oxidized DCFDA and flow cytometry. In: Armstrong D, editor. Advanced protocols in oxidative stress II, Methods in Molecular Biology. New York: Humana Press; 2010. p. 57-72.10.1007/978-1-60761-411-1_4]Search in Google Scholar
[15. Martin SJ, Reutelingsperger CEM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-56.10.1084/jem.182.5.1545]Search in Google Scholar
[16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.10.1016/0022-1759(95)00072-I]Search in Google Scholar
[17. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994; 170: 145-57.10.1016/0022-1759(94)90390-5]Search in Google Scholar
[18. Todorovic V, Sersa G, Mlakar V, Glavac D, Cemazar M. Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin. Radiol Oncol 2012; 46: 32-45.10.2478/v10019-012-0010-6342376022933978]Search in Google Scholar
[19. Vranic A. New developments in surgery of malignant gliomas. Radiol Oncol 2011; 45: 159-65.10.2478/v10019-011-0018-3342373622933950]Search in Google Scholar
[20. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, et al. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 2001; 20: 1193-202.10.1038/sj.onc.120422111313863]Search in Google Scholar
[21. Belmokhtar CA, Hillion J, Ségal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 2001; 20: 3354-62.10.1038/sj.onc.120443611423986]Search in Google Scholar
[22. Xue LY, Chiu SM, Oleinick NL. Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3 dependent steps of apoptosis and the critical lethal lesions. Exp Cell Res 2003; 283: 135-45.10.1016/S0014-4827(02)00032-0]Search in Google Scholar
[23. Zhang XD, Gillespie SK, Hersey P. Staurosporine induces apoptosis of melanoma by both caspase dependent and independent apoptotic pathways. Mol Cancer Ther 2004; 3: 187-97.10.1158/1535-7163.187.3.2]Search in Google Scholar
[24. D’Alimonte I, Ballerini P, Nargi E, Buccella S, Giuliani P, Di Iorio P, et al. Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation. Neurosci Lett 2007; 418: 66-71.10.1016/j.neulet.2007.02.06117400382]Search in Google Scholar
[25. Kim SY, Morgan MJ, Choksi S, Liu ZG. TNF induced activation of the Nox 1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007; 26: 675-87.10.1016/j.molcel.2007.04.02117560373]Search in Google Scholar
[26. Song JH, Bellail A, Tse MCL, Wee Yong V, Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis inducing ligand induced apoptosis. J Neurosci 2006; 26: 3299-308.10.1523/JNEUROSCI.5572-05.2006667408616554480]Search in Google Scholar
[27. Sharon Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in Response to extensive DNA damage via TNF-α feedforward signaling. Cell 2011; 145: 92-103.10.1016/j.cell.2011.02.02321458669]Search in Google Scholar
[28. Mao H, Lebrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest 2012, 30: 48-56.10.3109/07357907.2011.630050379988422236189]Search in Google Scholar